IL6 and pancreatic neoplasm: Additionally, CAF-secreted IL-6 increased glycolytic flux in pancreatic tumor cells and lactate efflux in the microenvironment, favoring the activation of M2 macrophages in the TME and excluding CD8+ T cells [99].